Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy

ConclusionsThis study found no association between Hb count or RBC transfusions and outcome. The daily practice of maintaining the Hb count above 12 g/dL during CCRT should be weighed against the potential risks of transfusions. Drops in WBC and PMN counts during treatment positively impacted OS and RFS and could, therefore, serve as biomarkers during CCRT to adapt the follow‐up and consider the need for adjuvant systemic treatments.

https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.3465?af=R

Source: Cancer Medicine - September 19, 2020 Category: Cancer & Oncology Authors: Christine Gennigens, Marjolein De Cuypere, Laurence Seidel, Johanne Hermesse, Annelore Barbeaux, Fr édéric Forget, Adelin Albert, Guy Jerusalem, Frédéric Kridelka Tags: ORIGINAL RESEARCH Source Type: research